Adicet Bio Faces Delisting Concerns
Ticker: ACET · Form: 8-K · Filed: Apr 11, 2025 · CIK: 1720580
| Field | Detail |
|---|---|
| Company | Adicet Bio, Inc. (ACET) |
| Form Type | 8-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Adicet Bio might get kicked off the exchange - big trouble.
AI Summary
Adicet Bio, Inc. filed an 8-K on April 11, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event date being April 7, 2025. The company, formerly known as resTORbio, Inc., is incorporated in Delaware and headquartered in Boston, Massachusetts.
Why It Matters
This filing indicates potential issues with Adicet Bio's compliance with stock exchange listing requirements, which could lead to its shares being delisted.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and investor confidence.
Key Players & Entities
- Adicet Bio, Inc. (company) — Registrant
- resTORbio, Inc. (company) — Former company name
- April 07, 2025 (date) — Earliest event date
- April 11, 2025 (date) — Filing date
- 131 Dartmouth Street, Floor 3, Boston, Massachusetts 02116 (address) — Principal Executive Offices
FAQ
What specific listing rule or standard has Adicet Bio, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Adicet Bio, Inc. has failed to satisfy, only that a notice has been issued.
What is the earliest date of the event reported in this 8-K filing?
The earliest date of the event reported is April 07, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on April 11, 2025.
What was Adicet Bio, Inc.'s former company name?
Adicet Bio, Inc.'s former company name was resTORbio, Inc.
Where are Adicet Bio, Inc.'s principal executive offices located?
Adicet Bio, Inc.'s principal executive offices are located at 131 Dartmouth Street, Floor 3, Boston, Massachusetts 02116.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 11, 2025 regarding Adicet Bio, Inc. (ACET).